CN106905264A - A kind of method of synthesis A Zhalawei intermediates - Google Patents

A kind of method of synthesis A Zhalawei intermediates Download PDF

Info

Publication number
CN106905264A
CN106905264A CN201710237869.1A CN201710237869A CN106905264A CN 106905264 A CN106905264 A CN 106905264A CN 201710237869 A CN201710237869 A CN 201710237869A CN 106905264 A CN106905264 A CN 106905264A
Authority
CN
China
Prior art keywords
formula
compound
phenyl
catalyst
butylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710237869.1A
Other languages
Chinese (zh)
Other versions
CN106905264B (en
Inventor
姚彤
季锡平
毛联岗
冯武臻
徐嘉
杜姗姗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIANYUNGANG JARI PHARMACEUTICAL CO Ltd
Original Assignee
LIANYUNGANG JARI PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIANYUNGANG JARI PHARMACEUTICAL CO Ltd filed Critical LIANYUNGANG JARI PHARMACEUTICAL CO Ltd
Priority to CN201710237869.1A priority Critical patent/CN106905264B/en
Publication of CN106905264A publication Critical patent/CN106905264A/en
Application granted granted Critical
Publication of CN106905264B publication Critical patent/CN106905264B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/04Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with air or molecular oxygen
    • C07D301/06Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with air or molecular oxygen in the liquid phase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Abstract

The invention discloses the method for one kind synthesis PhenethyIamino t-butyl formate of A Zhalawei intermediate (1S, 2R) 1 epoxy ethyl 2, comprise the following steps:, there is asymmetric reduction aminating reaction in step 1, obtain the butylene of 4 phenyl of (S) 3 amino 1 in the case where chiral amino alcohol catalyst 1 is acted on by the ketone of 1 phenyl, 3 butylene 2 with 2 nitro-benzylamines;Step 2, the butylene of 4 phenyl of (S) 3 N t-butoxycarbonyl aminos 1 is obtained by the butylene of 4 phenyl of (S) 3 amino 1 and di-tert-butyl dicarbonate reaction protection amino;Step 3, be there is into epoxidation reaction with the oxygen in air in the presence of chiral helicene phenolic ketone iron complex catalyst 2 in the butylene of 4 phenyl of (S) 3 N t-butoxycarbonyl aminos 1, the PhenethyIamino t-butyl formate of (1S, 2R) 1 epoxy ethyl 2 is obtained.A Zhalawei important intermediates (the 1S that the present invention is provided, 2R) the synthetic method raw material of the PhenethyIamino t-butyl formate of 1 epoxy ethyl 2 is cheap and easy to get, reaction condition is gentle, it is easy to operate, combined coefficient is high, it is suitable to industrialized production, a new approach is provided to prepare A Zhalawei and intermediate.

Description

A kind of method of synthesis A Zhalawei intermediates
Technical field
The invention belongs to organic preparing technical field, and in particular to a kind of A Zhalawei intermediates (1S, 2R) -1- epoxy second The synthetic method of base -2- PhenethyIamino t-butyl formates.
Background technology
Sulfuric acid A Zhalawei (formula A), is developed by Bristol-Myers Squibb Co. of the U.S., and in June, 2003 is first in the U.S. Listing, trade name is sharp to end appropriate (REYATAZ).Sulfuric acid A Zhalawei is current anti-AIDS drug topmost in the world, should Medicine can continue potent suppression AIDS virus, therefore, only needing to take 1 time daily, adverse reaction is few, with other anti HIV-1 virus Infection medicine is compared, also with absorbing that rapid, drug resistance is low, medication is convenient, the Small side effects to fat metabolism, during taking medicine The advantages of not disturbing normal diet.Research with other antiretroviral drugs it is also shown that be combined, treatment inhibition of HIV infection effect Fruit is more preferably.
The existing document report of the preparation method of sulfuric acid A Zhalawei, mainly with formula (I) compound (1S, 2R) -1- epoxy second Base -2- PhenethyIaminos t-butyl formate and 2- [4- (2- pyridine radicals) benzyl]-hydrazine carboxylic acid's tert-butyl ester are raw material, through open loop, water Solution, amine solution and into salt etc. reaction prepare.
Synthetic route is:
Formula (I) compound (1S, 2R) -1- epoxy ethyl -2- PhenethyIamino t-butyl formates are synthesis sulfuric acid A Zhala The key compound of Wei, the chiral epoxy compound has two chiral centres, and complex structure, synthesis difficulty is higher, to sulfuric acid The synthesis of A Zhalawei has great importance.Formula (I) compound (1S, 2R) -1- epoxy ethyl -2- benzene second has been related to it at present The report of carbamate, chemical synthesis process be mainly with the chiral ortho dihydroxylic alcohols containing protected amino as rise Beginning raw material, is obtained through the reaction such as class, partial hydrolysis and oxirane.
Synthetic route is:
The synthetic method is not related to the structure of chiral centre, and initiation material is to be protected containing two amino of chiral centre Chiral ortho dihydroxylic alcohols, the compound be difficult synthesis, be difficult to obtain, price costly, is unsuitable for large-scale production.
Chinese patent CN103468757 and CN104911224 with compound B as initiation material, by the ketone carbonyl in compound B By the method asymmetric reduction of enzymatic into chiral amino alcohol C, chiral amino alcohol C obtains formula to base by the reaction such as cyclization again (I) compound.
The method is related to a structure for chiral centre, and initial compounds B is, containing an amino ketones for chiral centre, to be somebody's turn to do Compound also is difficult to synthesis, is difficult to obtain, and price is also costly;In addition, the synthetic method need to be in the catalysis of biological reducing enzyme Under carry out, general biology enzyme is not readily available, therefore, also limit the industrial applications prospect of the method.
The content of the invention
The technical problems to be solved by the invention be overcome existing preparation formula (I) compound (1S, 2R) -1- epoxy ethyls - 2- PhenethyIaminos t-butyl formate report technology in raw material be not easy to obtain, it is expensive, be unable to industrial-scale production lack Fall into, there is provided a kind of effective side for preparing formula (I) compound (1S, 2R) -1- epoxy ethyl -2- PhenethyIamino t-butyl formates Method, the method raw material is cheap and easy to get, reaction condition is gentle, easy to operate, combined coefficient is high, environmentally friendly, is adapted to scale life Produce.
Technical scheme is summarized as follows:
Step (1), formula (II) compound 1- phenyl -3- butene-2s -one is sent out under the effect of catalyst 1 with 2- nitro-benzylamines Raw asymmetric reduction aminating reaction, obtains formula (III) compound (S) -3- amino-4-phenyl -1- butylene;Step (2), formula (III) compound and di-tert-butyl dicarbonate reaction protection amino are that formula (IV) compound (S) -3-N- tertbutyloxycarbonyl ammonia is obtained Base -4- phenyl -1- butylene;There is epoxy with the oxygen in air in the presence of catalyst 2 in step (3), formula (IV) compound Change reaction, obtain formula (I) compound (1S, 2R) -1- epoxy ethyl -2- PhenethyIamino t-butyl formates.
Synthetic route is:
Catalyst 1 in described step (1) is chiral amino alcohol, and structure is:
R in catalyst structure1It is hydrogen atom, C1~C4Alkyl, nitro, halogen etc..
The catalyst efficiency is very high, and its consumption is only the 3~8% of the amount of formula (II) combinations of materials.
Catalyst 2 in described step (3) is chiral helicene phenolic ketone iron complex, and structure is:
R in the catalyst structure2It is hydrogen atom, C1~C4Alkyl, halogen etc..
The catalyst is in hgher efficiency, and its consumption is only the 2~5% of the amount of formula (IV) combinations of materials.
Formula (I) compound (1S, the 2R) -1- epoxy ethyl -2- PhenethyIaminos t-butyl formate prepared with this technique Three steps are needed, with cheap non-chiral compound as initiation material, two chiral centres is constructed, total recovery is changed up to more than 65% Purity is learned up to 98%, optical purity is up to more than 98%.
Specific embodiment
With reference to specific embodiment is implemented, the present invention is further illustrated.It should be understood that these embodiments are merely to illustrate this Invention rather than limitation the scope of the present invention.
Raw material used or reagent are commercially available in addition to special instruction in embodiment.
The preparation of embodiment 1 formula (III) compound (S) -3- amino-4-phenyl -1- butylene
By 10mmol1- phenyl -3- butene-2s -one, 10mmol 2- nitro-benzylamines, 2.0gMolecular sieve and 20mL dichloros Methane is added in reaction bulb, is uniformly mixed.System temperature is risen into 60~70 DEG C, and the lower stirring reaction 3h of temperature herein, is stopped Only heat, treat that system temperature is down to 30~40 DEG C, by (the R of 0.5mmol catalyst 11=Cl) and the addition of 20mL dichloromethane, maintain System temperature is further continued for stirring reaction 4h at 30~40 DEG C, stops reaction, is filtered off after coolingThe solid matters such as molecular sieve, room To 20mL 4N HCl are added in filtrate under temperature, stood after stirring 1h, separate organic layer, washed with 5mL 4N HCl, merge water Layer, 8.5 are transferred to sodium carbonate solid by water layer pH value, add 50mL dichloromethane, separate organic layer, use anhydrous sodium sulfate drying Decompression afterwards boils off solvent, obtains formula (III) compound, yield 85%, ee values 97.5%.
The preparation of embodiment 2 formula (III) compound (S) -3- amino-4-phenyl -1- butylene
By 10mmol 1- phenyl -3- butene-2s -one, 10mmol 2- nitroanilines, 2.0gMolecular sieve and 20mL dichloros Methane is added in reaction bulb, is uniformly mixed.System temperature is risen into 60~70 DEG C, and the lower stirring reaction 3h of temperature herein, is stopped Only heat, treat that system temperature is down to 35~45 DEG C, by (the R of 0.6mmol catalyst 11=Me) and the addition of 20mL dichloromethane, maintain System temperature is further continued for stirring reaction 5h at 35~45 DEG C, stops reaction, is filtered off after coolingThe solid matters such as molecular sieve, room To 20mL 4N HCl are added in filtrate under temperature, stood after stirring 1h, separate organic layer, washed with 5mL 4N HCl, merge water Layer, 8.5 are transferred to sodium carbonate solid by water layer pH value, add 50mL dichloromethane, separate organic layer, use anhydrous sodium sulfate drying Decompression afterwards boils off solvent, obtains formula (III) compound, yield 81%, ee values 94%.
The preparation of embodiment 3 formula (IV) compound (S) -3-N- t-butoxycarbonyl amino -4- phenyl -1- butylene
By 10mmol formulas (III) compound, 0.7mmol potassium carbonate, 13mmol di-tert-butyl dicarbonates and 30mL tetrahydrochysene furans Mutter in addition reaction bulb, be uniformly mixed rear room temperature reaction 10 hours.Decompression boils off solvent, and 50mL oil is added to residue Ether, then pH value to 1 is adjusted with 4M HCl, the solid that suction filtration is separated out, drying under reduced pressure obtains formula (IV) compound, yield 98%.
The preparation of embodiment 4 formula (I) compound (1S, 2R) -1- epoxy ethyl -2- PhenethyIamino t-butyl formates
By the butyraldehyde and the (R of 0.18mmol catalyst 2 of 6mmol formulas (IV) compound, 36mmol newly distillation2=Me) and 50mL dichloroethanes is added, and dry air is passed through with the flow of 15mL/min, in 35~45 DEG C of stirring reaction 6h, is stopped anti- Should, with saturated sodium bicarbonate solution washing reaction mixture, branch vibration layer uses ether aqueous layer extracted, merges organic layer, with anhydrous Decompression boils off solvent after sodium sulphate is dried, and obtains the mixture recrystallization of crude product, crude product ethyl acetate and petroleum ether, obtains formula (I) compound, yield 80%, ee values 98.2%.
The preparation of embodiment 4 formula (I) compound (1S, 2R) -1- epoxy ethyl -2- PhenethyIamino t-butyl formates
By the butyraldehyde and the (R of 0.24mmol catalyst 2 of 6mmol formulas (IV) compound, 36mmol newly distillation2=Cl) and 50mL dichloroethanes is added, and dry air is passed through with the flow of 15mL/min, in 30~40 DEG C of stirring reaction 8h, is stopped anti- Should, with saturated sodium bicarbonate solution washing reaction mixture, branch vibration layer uses ether aqueous layer extracted, merges organic layer, with anhydrous Decompression boils off solvent after sodium sulphate is dried, and obtains the mixture recrystallization of crude product, crude product ethyl acetate and petroleum ether, obtains formula (I) compound, yield 77%, ee values 95.2%.

Claims (3)

1. A Zhalawei intermediate (1S, 2R) -1- epoxy ethyl -2- PhenethyIamino formic acid tertiary fourth of the one kind as shown in formula (I) The synthetic method of ester, the reaction equation of the synthetic method is:
It is characterized in that comprising the following steps:
Step (1), formula (II) compound 1- phenyl -3- butene-2s -one is occurred not under the effect of catalyst 1 with 2- nitro-benzylamines Asymmetric reduction aminating reaction, obtains formula (III) compound (S) -3- amino-4-phenyl -1- butylene;
Step (2), formula (III) compound obtains formula (IV) compound (S) -3-N- with di-tert-butyl dicarbonate reaction protection amino T-butoxycarbonyl amino -4- phenyl -1- butylene;
There is epoxidation reaction in step (3), formula (IV) compound, that is, formula is obtained under the effect of catalyst 2 with the oxygen in air (I) compound (1S, 2R) -1- epoxy ethyl -2- PhenethyIamino t-butyl formates;Catalyst 1 in described step (1) is Chiral amino alcohol, structure is:
Wherein R1It is hydrogen atom, C1~C4Alkyl, nitro, halogen;
Catalyst 2 in described step (3) is chiral helicene phenolic ketone iron complex, and structure is:
Wherein R2It is hydrogen atom, C1~C4Alkyl, halogen.
2. the synthetic method of a kind of A Zhalawei intermediates according to claim 1, it is characterised in that:Described step (1) consumption of the catalyst 1 in is only the 3~8% of the amount of formula (II) combinations of materials.
3. the synthetic method of a kind of A Zhalawei intermediates according to claim 1, it is characterised in that:Described step (2) consumption of the catalyst 2 in is only the 2~5% of the amount of formula (IV) combinations of materials.
CN201710237869.1A 2017-04-12 2017-04-12 A method of synthesis A Zhalawei intermediate Active CN106905264B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710237869.1A CN106905264B (en) 2017-04-12 2017-04-12 A method of synthesis A Zhalawei intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710237869.1A CN106905264B (en) 2017-04-12 2017-04-12 A method of synthesis A Zhalawei intermediate

Publications (2)

Publication Number Publication Date
CN106905264A true CN106905264A (en) 2017-06-30
CN106905264B CN106905264B (en) 2019-06-07

Family

ID=59196033

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710237869.1A Active CN106905264B (en) 2017-04-12 2017-04-12 A method of synthesis A Zhalawei intermediate

Country Status (1)

Country Link
CN (1) CN106905264B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238589A (en) * 1973-03-05 1980-12-09 Hoffmann-La Roche Inc. Fluorogenic materials and labeling techniques
US20090270499A1 (en) * 2008-04-24 2009-10-29 Oxyrane (Uk) Limited Process for Synthesizing Atazanavir
WO2009136365A1 (en) * 2008-05-08 2009-11-12 Ranbaxy Laboratories Limited Process for the preparation of 3,4-epoxy-2-amino-1-substituted butane derivatives and intermediate compounds thereof
CN103951588A (en) * 2014-04-30 2014-07-30 淮海工学院 Method of synthesizing saxagliptin intermediate N-t-butyloxycarboryl-3-hydroxyl-1-adamantyl-D-glycine
CN104220451A (en) * 2012-02-15 2014-12-17 百时美施贵宝公司 C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
CN104803954A (en) * 2015-04-30 2015-07-29 上海应用技术学院 Preparation method for fosamprenir intermediate

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238589A (en) * 1973-03-05 1980-12-09 Hoffmann-La Roche Inc. Fluorogenic materials and labeling techniques
US20090270499A1 (en) * 2008-04-24 2009-10-29 Oxyrane (Uk) Limited Process for Synthesizing Atazanavir
WO2009136365A1 (en) * 2008-05-08 2009-11-12 Ranbaxy Laboratories Limited Process for the preparation of 3,4-epoxy-2-amino-1-substituted butane derivatives and intermediate compounds thereof
CN104220451A (en) * 2012-02-15 2014-12-17 百时美施贵宝公司 C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
CN103951588A (en) * 2014-04-30 2014-07-30 淮海工学院 Method of synthesizing saxagliptin intermediate N-t-butyloxycarboryl-3-hydroxyl-1-adamantyl-D-glycine
CN104803954A (en) * 2015-04-30 2015-07-29 上海应用技术学院 Preparation method for fosamprenir intermediate

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
XIAO XIAO ET AL.,: "Organocatalytic Asymmetric Biomimetic Transamination:From α-Keto Esters to Optically Active α-Amino Acid Derivatives", 《J. AM. CHEM. SOC.》 *
YUN SHEN ET AL.,: "Dioxygen-Triggered Transannular Dearomatization of Benzo[5]helicene Diols: Highly Efficient Synthesis of Chiral π-Extended Diones", 《ANGEW. CHEM. INT. ED.》 *
唐除痴 等,: "《不对称反应中的有机磷试剂》", 31 October 2012, 南开大学出版社 *
施梅 等,: "基于D-木糖的新型手性氨基醇的合成", 《南京晓庄学院学报》 *
无: "分子氧诱导螺烯二酚跨环去芳构化反应:手性二酮的高效合成", 《有机化学》 *
李岩云 等,: "手性铁催化体系在不对称催化中的应用研究", 《分子催化》 *
程青芳 等,: "手性方酞胺基醇钛合物诱导的芳醛的不对称口片呐醇偶联反应", 《有机化学》 *
程青芳 等,: "龙脑基β-二酮铁配合物催化的苯乙烯类化合物的不对称环氧化反应", 《化学学报》 *
葛新: "还原胺化反应的应用及其机理研究", 《中国博士学位论文全文数据库 工程科技I辑》 *

Also Published As

Publication number Publication date
CN106905264B (en) 2019-06-07

Similar Documents

Publication Publication Date Title
CN109516998B (en) Synthesis method of Barosavir intermediate
CN103265528B (en) Esomeprazole magnesium preparation method
CN108675943A (en) The preparation method of one planting sand library Ba Qu key intermediates
US10189760B2 (en) Method for preparing sitagliptin intermediate via asymmetrical reduction method
CN101274915A (en) Method for synthesizing isoxazole
CN104774174B (en) A kind of method of asymmetric syntheses S carbinoxamines
CN106496199A (en) His Wei of Dacca and its preparation method of intermediate
CN109942514B (en) Method for preparing azalazavir sulfate intermediate
CN103044468B (en) Preparation method of N-(2-pyrazine carbonyl)-L-phenylalanine-L- leucine boracic acid
Ranu et al. Using more environmentally friendly solvents and benign catalysts in performing conventional organic reactions
CN102010327B (en) Splitting method of (+/-)-2-(3-benzoyl)-phenylpropionic acid
CN106905264A (en) A kind of method of synthesis A Zhalawei intermediates
CN108467353B (en) Preparation method of enantiopure tert-butyl sulfinamide
CN103951588B (en) A kind of method synthesizing onglyza intermediate N-tertbutyloxycarbonyl-3-hydroxyl-1-adamantyl-D-glycine
CN105418477B (en) The method for reducing diastereoisomer impurity content in Lei Dipawei intermediate
CN114315609A (en) Process for preparing cis-2-aminocyclohexanol
CN103467350B (en) (S) preparation method of-AzeOH
CN102807516A (en) Intermediate in amisulpride and method for preparing amisulpride by using intermediate
CN104803998A (en) Impurity content decreasing method
CN101747294B (en) Method for purifying N-(2,6-xylyl)-2-(1-piperazinyl)acetamide
CN103224489B (en) Method for enhancing production yield and rate of esomeprazole
CN109369553A (en) A method of efficiently synthesizing N-3- isoxazole t-butyl carbamate
CN107383076A (en) A kind of synthetic method of the chlorophenylboronic acid pinacol ester of 3 amino 4
CN102603518A (en) Resolution method for 2-chloromandelic acid by crystalizing diastereomeric salts
CN106083624B (en) The one pot process technique of 3- amino -3- phenylpropionic acid esters

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant